Recorded webinars wtih Professor Richard Costello and Professor David Price

Professor David Price: Current unmet needs & goals of inhalation therapies

 

Professor Richard Costello: How digital innovations could help HCPs achieve inhalation treatment goals

 

Rate this content: 
No votes yet
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.